From groundbreaking data presented at ACC 2025 to emerging trends, this webinar provides an in-depth analysis of the latest data and key takeaways shaping the future of cardiovascular drug development. Our panel of experts examines novel therapeutic targets, biomarker-driven study designs, and real-world evidence strategies that can help sponsors looking to optimize trial design and execution in an increasingly competitive space. Key discussions include:
- Advancements in early phase trial methodologies
- Integration of digital health technologies
- Role of precision medicine in enhancing patient stratification.
Whether you’re advancing a first-in-human asset or scaling a global Phase III program, watch on-demand to discover real-world learnings to inform your next steps in cardiovascular development.
